Concepts (95)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Lichen Planus | 2 | 2020 | 60 | 0.95 | Why? |
| Dermatitis, Contact | 2 | 2020 | 98 | 0.95 | Why? |
| Stevens-Johnson Syndrome | 2 | 2021 | 129 | 0.95 | Why? |
| Sulfasalazine | 1 | 2021 | 87 | 0.89 | Why? |
| Mucinoses | 1 | 2018 | 26 | 0.79 | Why? |
| Dermatitis, Occupational | 2 | 2021 | 310 | 0.74 | Why? |
| Gloves, Protective | 1 | 2020 | 249 | 0.73 | Why? |
| Lasers, Solid-State | 1 | 2018 | 56 | 0.72 | Why? |
| Skin Aging | 1 | 2018 | 55 | 0.70 | Why? |
| Prednisolone | 1 | 2018 | 443 | 0.59 | Why? |
| Face | 1 | 2018 | 301 | 0.57 | Why? |
| Skin Diseases | 3 | 2020 | 2509 | 0.54 | Why? |
| Hand Hygiene | 1 | 2020 | 1493 | 0.40 | Why? |
| Lupus Erythematosus, Systemic | 1 | 2020 | 1380 | 0.39 | Why? |
| Arthritis, Rheumatoid | 1 | 2021 | 2043 | 0.34 | Why? |
| Immunoglobulins, Intravenous | 1 | 2018 | 2705 | 0.32 | Why? |
| Antirheumatic Agents | 1 | 2021 | 3023 | 0.31 | Why? |
| Psoriasis | 1 | 2020 | 1739 | 0.31 | Why? |
| Glucocorticoids | 2 | 2018 | 4431 | 0.30 | Why? |
| Soaps | 1 | 2020 | 134 | 0.20 | Why? |
| Meibomian Glands | 1 | 2018 | 9 | 0.19 | Why? |
| Eyelid Diseases | 1 | 2018 | 15 | 0.19 | Why? |
| Vasculitis, Leukocytoclastic, Cutaneous | 1 | 2020 | 88 | 0.19 | Why? |
| Lead Poisoning | 1 | 2018 | 9 | 0.18 | Why? |
| Hair Diseases | 1 | 2018 | 31 | 0.18 | Why? |
| Tramadol | 1 | 2018 | 40 | 0.17 | Why? |
| Eczema | 1 | 2021 | 227 | 0.17 | Why? |
| Hydroxychloroquine | 2 | 2020 | 12447 | 0.17 | Why? |
| Dry Eye Syndromes | 1 | 2018 | 113 | 0.16 | Why? |
| Pneumonia, Viral | 7 | 2021 | 243684 | 0.16 | Why? |
| Corneal Diseases | 1 | 2018 | 172 | 0.15 | Why? |
| Personal Protective Equipment | 1 | 2020 | 15978 | 0.15 | Why? |
| Pemphigus | 1 | 2018 | 163 | 0.15 | Why? |
| Methadone | 1 | 2018 | 296 | 0.14 | Why? |
| Pandemics | 7 | 2021 | 389249 | 0.14 | Why? |
| Urticaria | 1 | 2020 | 472 | 0.13 | Why? |
| Anti-Infective Agents, Local | 1 | 2020 | 520 | 0.13 | Why? |
| Iran | 3 | 2020 | 5467 | 0.13 | Why? |
| Coronavirus Infections | 6 | 2020 | 253789 | 0.12 | Why? |
| Drug Interactions | 1 | 2020 | 1653 | 0.12 | Why? |
| Fatal Outcome | 1 | 2021 | 3438 | 0.11 | Why? |
| Betacoronavirus | 5 | 2020 | 204454 | 0.10 | Why? |
| Exanthema | 1 | 2020 | 1097 | 0.10 | Why? |
| Disinfectants | 1 | 2020 | 1077 | 0.10 | Why? |
| Heart Rate | 1 | 2018 | 1527 | 0.09 | Why? |
| Methylprednisolone | 1 | 2018 | 2107 | 0.08 | Why? |
| Double-Blind Method | 1 | 2018 | 5988 | 0.08 | Why? |
| Humans | 17 | 2021 | 930598 | 0.08 | Why? |
| Treatment Outcome | 4 | 2020 | 51732 | 0.08 | Why? |
| Health Personnel | 3 | 2021 | 29646 | 0.08 | Why? |
| Patient Satisfaction | 1 | 2018 | 2517 | 0.07 | Why? |
| Arrhythmias, Cardiac | 1 | 2018 | 2510 | 0.07 | Why? |
| Antineoplastic Agents | 1 | 2020 | 3550 | 0.07 | Why? |
| Length of Stay | 1 | 2020 | 11042 | 0.06 | Why? |
| Immunosuppressive Agents | 1 | 2020 | 6331 | 0.06 | Why? |
| Eyelashes | 1 | 2018 | 4 | 0.05 | Why? |
| Eyebrows | 1 | 2018 | 14 | 0.05 | Why? |
| Histamine Antagonists | 1 | 2020 | 203 | 0.05 | Why? |
| Time Factors | 2 | 2020 | 31397 | 0.05 | Why? |
| Pulse Therapy, Drug | 1 | 2018 | 137 | 0.05 | Why? |
| Poisons | 1 | 2018 | 26 | 0.04 | Why? |
| Middle Aged | 7 | 2021 | 270681 | 0.04 | Why? |
| Hyperpigmentation | 1 | 2018 | 42 | 0.04 | Why? |
| Lead | 1 | 2018 | 94 | 0.04 | Why? |
| Leg | 1 | 2018 | 142 | 0.04 | Why? |
| Hand Dermatoses | 1 | 2021 | 284 | 0.04 | Why? |
| Risk Assessment | 1 | 2020 | 25439 | 0.04 | Why? |
| Female | 7 | 2021 | 380317 | 0.04 | Why? |
| Tears | 1 | 2018 | 400 | 0.03 | Why? |
| Self-Injurious Behavior | 1 | 2018 | 391 | 0.03 | Why? |
| Conjunctiva | 1 | 2018 | 620 | 0.03 | Why? |
| Lung | 1 | 2020 | 31049 | 0.03 | Why? |
| Drug Overdose | 1 | 2018 | 583 | 0.03 | Why? |
| Adult | 5 | 2020 | 244371 | 0.03 | Why? |
| Recurrence | 1 | 2020 | 3675 | 0.03 | Why? |
| Intention | 1 | 2018 | 1380 | 0.02 | Why? |
| Self Report | 1 | 2021 | 3802 | 0.02 | Why? |
| Skin | 1 | 2020 | 2096 | 0.02 | Why? |
| Male | 5 | 2020 | 367725 | 0.02 | Why? |
| Drug Therapy, Combination | 1 | 2020 | 7268 | 0.02 | Why? |
| Azithromycin | 1 | 2020 | 3943 | 0.02 | Why? |
| Prospective Studies | 2 | 2018 | 43301 | 0.02 | Why? |
| Risk Factors | 2 | 2021 | 71621 | 0.01 | Why? |
| Case-Control Studies | 1 | 2018 | 17671 | 0.01 | Why? |
| Aged, 80 and over | 2 | 2020 | 88759 | 0.01 | Why? |
| Peptidyl-Dipeptidase A | 1 | 2020 | 9659 | 0.01 | Why? |
| Prevalence | 1 | 2021 | 25773 | 0.01 | Why? |
| Aged | 3 | 2020 | 215776 | 0.01 | Why? |
| Young Adult | 2 | 2018 | 93724 | 0.01 | Why? |
| China | 1 | 2020 | 50654 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2021 | 48226 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2018 | 53120 | 0.01 | Why? |
| Retrospective Studies | 1 | 2020 | 105322 | 0.01 | Why? |
| Adolescent | 1 | 2018 | 86841 | 0.01 | Why? |
| Hospitalization | 1 | 2018 | 54280 | 0.00 | Why? |